Issue Date: April 16, 2007
Pfizer Seeks New Uses For Drugs
Pfizer has signed two pacts aimed at finding new markets for drugs in its pipeline. Caliper Life Sciences will conduct in vivo drug-profiling experiments for compounds in Pfizer's pipeline to determine whether new indications can be pursued for them. Under the one-year contract, Caliper will study the effects of acute or chronic drug dosing in mice. In a separate agreement, Melior Discovery will deploy its in vivo theraTrace indications discovery platform to determine the activity of Pfizer compounds.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society